SCHEMBL20683182

SCHEMBL20683182

C=C/C(=C\c1c(C)n(-c2ccccc2)c2ccccc12)c1ccc2c(c1)c1ccccc1n2/C(C=C)=C/C=C\C

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 1/20 0.32
▸ KDM4E B2RXH2 4/20 0.32
▸ GAA P10253 1/20 0.31
▸ GFER P55789 1/20 0.31
▸ HPGD P15428 2/20 0.31
▸ ATM Q13315 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ PTGER4 P35408 1/20 0.30
▸ PLA2G2A P14555 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ PKM P14618 1/20 0.30
▸ ALOX15 P16050 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22408862 0.87 KDM4E (0.42) RORCKDM4EGAAGFERHPGD
SCHEMBL25024928 0.82 KDM4E (0.38) RORCKDM4EGAAGFERHPGD
SCHEMBL18542855 0.81 RORC (0.38) RORCKDM4EGAAGFERHPGD
SCHEMBL16214792 0.79 KDM4E (0.42) KDM4EGAAGFERHPGDATM
SCHEMBL25737373 0.78 PTGER4 (0.35) RORCKDM4EGAAGFERHPGD
SCHEMBL21023613 0.77 HPGD (0.33) KDM4EGAAGFERHPGDLMNA
SCHEMBL24398609 0.76 RORC (0.37) RORCKDM4EGAAGFERHPGD
SCHEMBL25727603 0.75 TSPO (0.38) KDM4EATML3MBTL1LMNAPTGER4
SCHEMBL24703501 0.75 LMNA (0.38) RORCKDM4ELMNAHTTSMN1; SMN2
SCHEMBL24631962 0.75 RORC (0.34) RORCKDM4EGAAGFERHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10193077-B2 Biscarbazole derivative, material for organic electroluminescence device and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2019-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10193077-B2 Biscarbazole derivative, material for organic electroluminescence device and organic electroluminescence device using the same UQCRB, OXA1L, HBS1L RORC 941/4885KDM4E 984/4885GAA 3496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback